Showing results (211-220 of 361) with videos related to

Sort By:
Pageof 37
Non-Coding RNA|October 27, 2023
Discovery and Comprehensive Characterization of Novel Circular RNAs of the Apoptosis-Related BOK Gene in Human Ovarian and Prostate Cancer Cells, Using Nanopore SequencingChristos K Kontos, Despina Hadjichambi, Maria Papatsirou, et al.
Journal of Cancer Research and Clinical Oncology|May 19, 2015
Overexpression of BCL2 and BAX following BFM induction therapy predicts ch-ALL patients' poor response to treatment and short-term relapseLamprini Stamati, Margaritis Avgeris, Helen Kosmidis, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 14, 2011
Clinical evaluation of PRMT1 gene expression in breast cancerKonstantina Mathioudaki, Andreas Scorilas, Alexandros Ardavanis, et al.
The Prostate|April 12, 2002
Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissuesGeorge M Yousef, Andreas Scorilas, Albert Chang, et al.
Analytical and Bioanalytical Chemistry|September 2, 2017
Multianalyte quantitative competitive PCR on optically encoded microspheres for an eight-gene panel related to prostate cancerIraklis K Kyriakou, Konstantinos Mavridis, Despina P Kalogianni, et al.
Clinical Biochemistry|May 1, 2016
High BAX/BCL2 mRNA ratio predicts favorable prognosis in laryngeal squamous cell carcinoma, particularly in patients with negative lymph nodes at the time of diagnosisAris I Giotakis, Christos K Kontos, Leonidas D Manolopoulos, et al.
Oncotarget|December 31, 2016
Assessing the clinical value of microRNAs in formalin-fixed paraffin-embedded liposarcoma tissues: Overexpressed miR-155 is an indicator of poor prognosisNikolaos Kapodistrias, Konstantinos Mavridis, Anna Batistatou, et al.
European Journal of Clinical Investigation|February 7, 2012
Immunohistochemical expression of somatostatin receptor subtypes 2 and 5 in colorectal cancerIoulia Evangelou, Constantina Petraki, Pavlos Msaouel, et al.
Clinical Biochemistry|September 18, 2014
BCL2L12: a promising molecular prognostic biomarker in breast cancerAlexandros Tzovaras, Athina Kladi-Skandali, Kleita Michaelidou, et al.
Cancers|December 9, 2020
tRNA-Derived Fragments (tRFs) in Bladder Cancer: Increased 5'-tRF-LysCTT Results in Disease Early Progression and Patients' Poor Treatment OutcomeMaria-Alexandra Papadimitriou, Margaritis Avgeris, Panagiotis Levis, et al.
Pageof 37